Dr. Harsh Dua

MBBS, MD (Medicine), FICA, specialized training (Hematology/Oncology)

Senior Consultant – Department of Medical Oncology

35+ Years of Experience
Delhi NCR

Dr. Harsh Dua is a universally recognized giant and one of the most distinguished, longest-serving authorities in Medical Oncology in India, boasting over 35 years of elite clinical mastery. After completing his foundational medical degrees, he underwent intensive, advanced sub-specialty training in Hematology and Oncology at the world-renowned University Hospital Queen’s Medical Centre in Nottingham, England. Dr. Dua is globally celebrated for his deep clinical expertise in designing highly personalized, cutting-edge targeted therapies, immunotherapies, and customized chemotherapy protocols for solid tumors and blood cancers. Known for his profound personal integrity and compassionate, patient-first ethos, he believes in empowering families through complete clinical transparency and extensive disease education. Fluent in multiple languages, he provides a comforting, stress-free, and supportive healing environment for a vast demographic of domestic and multi-ethnic international patients. 

  • Solid Tumor Management: Structuring advanced, next-generation systemic therapies, molecular targeted agents, and immunotherapies for complex Head & Neck, Breast, Lung, and Gastrointestinal cancers.
  • Hematological Oncology: Comprehensive care and targeted induction regimens for adult leukemias, lymphomas, Multiple Myeloma, and complex non-malignant blood disorders.
  • Uro-Oncology & Hepatobiliary Cancer: Multidisciplinary medical oncology protocols to manage aggressive kidney, prostate, bladder, and advanced liver malignancies.
  • Multidisciplinary Tumor Board Care: Expertly collaborating with radiation and surgical oncology teams to craft highly effective, personalized trimodality treatment lines.
  • Maintained a stellar, high-volume clinical profile across Delhi’s premier cancer institutes, helping thousands of patients navigate complex oncology treatments with high success and safety rates.
  • Honored internationally with the prestigious Young Investigator of the Year Award (2001) in Canada, acknowledging his outstanding contributions to cancer research. 
  • Contributed monumentally to global medical academia, authoring more than 50 highly cited research papers published inside reputed international peer-reviewed oncology journals.
  • Awarded Fellow of the Indian College of Anesthesiologists (FICA) and an active Member of the Academy of Medical Sciences, Delhi.
  • Highly sought-after academic mentor who actively guides postgraduate oncology fellows and lectures at premier global symposia.
  • Renowned for maintaining exceptional long-term survival track records through the seamless integration of cutting-edge molecular tumor profiling.